The Therapeutic Potential of Epigenetic Modifications in Alzheimer’s Disease

  • Bufill E
  • Ribosa-Nogué R
  • Blesa R
N/ACitations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

ABSTRACT Alzheimer’s disease is characterized by the formation and deposit of abnormal peptides such as amyloid plaques and neurofibrillary tangles in the brain. Therapeutic strategies aimed at preventing the formation of such deposits have not been successful. Currently, there are no effective treatments for the disease. Since numerous epigenetic changes have been detected in Alzheimer’s disease, treatments aimed at reversing these changes by intervening in DNA methylation, histone acetylation, and microRNA expression may constitute promising lines of research in the future. This chapter provides an overview of the epigenetic changes and the potential epigenetic therapies in Alzheimer’s disease.

Cite

CITATION STYLE

APA

Bufill, E., Ribosa-Nogué, R., & Blesa, R. (2020). The Therapeutic Potential of Epigenetic Modifications in Alzheimer’s Disease. In Alzheimer’s Disease: Drug Discovery (pp. 151–164). Exon Publications. https://doi.org/10.36255/exonpublications.alzheimersdisease.2020.ch9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free